Overview
Airway Medix S.A. is a medical device company based in Poland, specializing in the development and manufacturing of innovative medical solutions aimed at improving patient care in the respiratory field. The company is particularly focused on addressing the challenges associated with mechanical ventilation and airway management in intensive care and anesthesia. One of their key projects includes the development of the Closed Suction System, designed to enhance the safety and effectiveness of suctioning in ventilated patients, thereby reducing the risk of ventilator-associated pneumonia. The company’s commitment to innovation is also demonstrated in its ongoing research and development efforts to refine and expand its product portfolio, leveraging advanced technology to meet the complex needs of respiratory care professionals and their patients.
AI+ Ask Fintel’s AI assistant about Airway Medix S.A..
Thinking about good questions…
Basic Stats
The share price of Airway Medix S.A. as of September 5, 2025 is PLN0.38 / share. This is an increase of 2.40% from the prior week. The market cap (or net worth) of Airway Medix S.A. as of September 5, 2025 is PLN28.27 MM.
The Factor Analysis chart (below right) shows a view of Airway Medix S.A. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 28.27 MM |
| EV | 49.35 MM |
| Shares Out. | 73.72 MM |
| Earnings Date | |
| EPS (TTM) | -0.15 |
| Dividend Yield | |
| Ex-Dividend Date | |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | 67.47 % |
| Volatility (1 yr) | 0.90 |
| Beta | 1.20 |
| Sharpe Ratio (1 yr) | 0.70 |
| Sortino Ratio (1 yr) | 1.89 |
| PE Ratio | -2.50 |
| Price/Book | -1.11 |
| Price/TBV | -1.11 |
| Book/Market | -0.90 |
| EBIT/EV | -0.23 |
| EBIT(3yr avg)/EV | -0.08 |
| ROA | -11.97 |
| ROE | |
| ROIC | |
| CROIC | |
| OCROIC | |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 47.24 /100 |
| Profitability | |
| Quality Score | |
| Value Score | 15.96 /100 |
| Momentum Score | 42.28 /100 |
| Stability (Low Vol) Score | 15.81 /100 |
| Analyst Sentiment | |
| Fund Sentiment | |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 3.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Airway Medix S.A.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| No data available. | ||||
